Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, ...
Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback